secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0001156039-24-000101
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q2 diluted EPS $9.85 (+26% YoY); revenue $43.2B, down $0.2B
---------------------------------------------------------------------------

- Adjusted diluted EPS $10.12 (+12% YoY); GAAP EPS at least $34.05 for FY2024, adjusted at least $37.20.
- Health Benefits revenue $37.2B (-2%); Carelon revenue $13.3B (+10%) on risk-based service growth.
- Medical membership 45.8M, down 5% YoY due to Medicaid redeterminations; partly offset by ACA growth.
- Benefit expense ratio improved 10 bps to 86.3%; operating expense ratio increased to 11.7%.
- Q3 dividend $1.63/share declared, payable Sept 25, 2024; $3.2B share repurchase authorization remaining.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603924000101/0001156039-24-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603924000101/elv-20240717.htm
  HTML page:      https://secwatch.observer/filing/0001156039-24-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer